CLINICAL_TRIALS
trial_result
· 2021-01-27
Clinical Trial Update: Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. [Phase 1]
Summary
Phase I dose-escalation study of efavirenz in solid tumors and non-Hodgkin lymphoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institut Bergonié | Conditions: Solid Tumors, Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2021-01-27